CERS6 and fatty liver disease: In liver-specific CerS6 knockout mice, researchers found that mitochondrial β-oxidation and hepatic lipid metabolism levels were significantly increased in BAT, which not only improved energy supply but also reduced hepatic steatosis and insulin resistance 82.